Stephen J. Schueler, M.D.

Overview Incidence Risk Factors Symptoms Evaluation Treatment drugs Warning Signs Prevention Underlying Cause

Altitude Brain Swelling Underlying Cause

There are a number of physical effects on the human body when exposed to high altitudes. These are mainly due to a lower percentage of oxygen and lower air pressure. For example, in Denver, Colorado (1610 m), the air pressure is 17 percent less than at sea level and contains 17 percent less oxygen.

Ascending to a higher altitude will decrease the amount of oxygen available to the body. When the ascent is too rapid, the body cannot compensate quickly enough. This results in high altitude illness.

The exact cause of this disorder remains unclear. It is most likely due the loss of oxygen.

Humans can adapt to lower oxygen levels at high altitude. This process of acclimatization generally takes days to weeks. Changes in breathing, red blood cell mass, fluid balance, and cardiovascular function make this adaptation possible.

Physiologic Divisions of High Altitude

AltitudeElevationEffects
High4,900-11,500 ftdecreased exercise performance, increased ventilation
Very high11,500-18,000 ftextreme low oxygen during sleep & activity
Extremely high>18,000 ftphysiologic decompensation in humans

Last Updated: Sep 9, 2010 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Altitude Brain Swelling References
  1. Basnyat B, Murdoch DR. High-altitude illness. Lancet. 2003 Jun 7;361(9373):1967-74. [12801752]
  2. Foster PP, Feiveson AH, Boriek AM. Predicting time to decompression illness during exercise at altitude, based on formation and growth of bubbles. Am J Physiol Regul Integr Comp Physiol. 2000 Dec;279(6):R2317-28. [11080100]
  3. Gallagher SA, Hackett PH. High-altitude illness. Emerg Med Clin North Am. 2004 May;22(2):329-55, viii. Review. [15163571]
  4. Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck PS. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ. 2004 Apr 3;328(7443):797. [15070635]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.